(Q98767321)
Statements
A single-center, open and dose-escalation phase I clinical trial for recombinant novel coronavirus vaccine (adenoviral vector) in healthy adults aged between 18 and 60 years (English)
0 references
在18至60周岁健康成人中开展重组新型冠状病毒疫苗（腺病毒载体）的单中心、开放性、剂量递增设计的Ⅰ期临床试验 (Chinese)
0 references
16 March 2020
0 references
31 December 2020
0 references
108
0 references